Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
-
Published:2021-10
Issue:10
Volume:21
Page:1349-1350
-
ISSN:1473-3099
-
Container-title:The Lancet Infectious Diseases
-
language:en
-
Short-container-title:The Lancet Infectious Diseases
Subject
Infectious Diseases
Reference5 articles.
1. Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India;Balsari;Lancet Infect Dis,2021
2. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial;Udwadia;Int J Infect Dis,2021
3. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19;Kory;Am J Therapeutics,2021
4. Frauds in scientific research and how to possibly overcome them;Boetto;J Med Ethics,2020
5. Clinical triage in a large 2000-bed COVID-19 care facility: role of the anesthesiologist;Kotnala;J Cardiothorac Vasc Anesth,2021